Immunotherapy Explained Part 2 – In Relation To Affimed. In part 3 here we explain and expand in the science of Immunotherapy and explain in part how $AFMD is differentiated, explain the $MRK Keytruda/AFM 13 trial plus a lot more.…
In this video, I talk about the federal reserve, why they can’t rates. Russia, China, America,Middle East hegemony, leverage, Oil. Deutsche Bank, Glencore, QE4, Stock Market outlook, the economy, debt verses wage growth, deflation, recession, and more.
Summary On May 28th, 2015, Fairway is scheduled to report its earnings from its last quarter. During the last quarter, the EURO dollar weakened substantially while the dollar gained. This factor has likely been over looked by the analysts covering…
Explanation on Current Market Situation Jan.29, 2014. $SPY reviewed later on in video. Mis-speak, I said “76 Million jobs” I later correct that to the proper “76 thousand jobs” I speak about potential head and shoulders in the charts, as…
Today at stockmatusow, we focus on a Bio-Pharmaceutical company with several near-term catalysts and give our thesis why we believe the company makes for a good long term speculative investment. Synergy Pharmaceuticals (SGYP) focuses on the development of drugs to…
Disclosure: I bought 25k shares of $PGNX @ $5.45 Biorunup’s Mark sold to go on vacation. Sheff remains bullish. we do as well. This is a pure catalyst trade which I talk about in my latest video. If Adcom for…
This week has been a strange market week for sure. I have held back on picks mainly because I want to see some clarity as I believe we are at a market top, and economic data has peaked out. Furthermore,…
Beginning points of Due Diligence for Athersys (ATHX) I am long the stock from $1.24. My Short Term catalyst Price Target opinion is $1.55 to $1.75, and $2.75 based on if positive Phase II data is reported. Multiple 2013 Catalysts…
